Week In Review: China Pharma Continues Record Deal Pace With $2 Billion In New Announcements
September 09, 2017 at 14:38 PM EDT
OrbiMed, a global healthcare investor, closed its third Asia private equity fund with $551 million in capital commitments, about $100 million more than the target listed in its initial filing six months ago.
